Jane Street Group LLC decreased its holdings in USANA Health Sciences, Inc. (NYSE:USNA – Free Report) by 51.1% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,298 shares of the company’s stock after selling 9,724 shares during the period. Jane Street Group LLC’s holdings in USANA Health Sciences were worth $353,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. State Street Corp increased its stake in USANA Health Sciences by 0.6% in the third quarter. State Street Corp now owns 435,164 shares of the company’s stock worth $16,501,000 after purchasing an additional 2,782 shares during the period. Safe Harbor Fiduciary LLC purchased a new stake in USANA Health Sciences in the third quarter worth $30,000. Centiva Capital LP purchased a new stake in USANA Health Sciences in the third quarter worth $213,000. Martingale Asset Management L P increased its stake in USANA Health Sciences by 2.1% in the third quarter. Martingale Asset Management L P now owns 16,732 shares of the company’s stock worth $634,000 after purchasing an additional 340 shares during the period. Finally, Pacer Advisors Inc. increased its stake in USANA Health Sciences by 16.5% in the third quarter. Pacer Advisors Inc. now owns 544,256 shares of the company’s stock worth $20,638,000 after purchasing an additional 76,904 shares during the period. Hedge funds and other institutional investors own 54.25% of the company’s stock.
USANA Health Sciences Trading Down 1.2 %
USNA opened at $34.90 on Thursday. USANA Health Sciences, Inc. has a 12-month low of $31.44 and a 12-month high of $52.75. The business’s fifty day simple moving average is $37.73 and its 200-day simple moving average is $39.33. The company has a market capitalization of $665.19 million, a price-to-earnings ratio of 12.33, a PEG ratio of 1.25 and a beta of 0.89.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently issued reports on USNA shares. DA Davidson increased their price target on USANA Health Sciences from $35.00 to $38.00 and gave the stock a “neutral” rating in a research report on Thursday, January 2nd. StockNews.com raised USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research report on Saturday, December 28th.
Check Out Our Latest Research Report on USNA
Insider Activity at USANA Health Sciences
In related news, Director Gilbert A. Fuller sold 675 shares of the firm’s stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $37.71, for a total transaction of $25,454.25. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. 0.33% of the stock is owned by corporate insiders.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Recommended Stories
- Five stocks we like better than USANA Health Sciences
- What is a Special Dividend?
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- The Risks of Owning Bonds
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- NYSE Stocks Give Investors a Variety of Quality Options
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA – Free Report).
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.